News Details - Moderna
WEBMar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
News Details - Moderna
WEBMar 27, 2024 · Announces positive clinical trial data from three new vaccines against viruses that cause significant burden (Epstein-Barr virus, Varicella-Zoster virus, norovirus) and advances programs toward Phase 3 development. Anticipates U.S. launch of vaccine against RSV following FDA approval and ACIP recommendation in 2024.
News Details - Moderna
WEBSep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · FDA approved and authorized for emergency use updated mRNA COVID-19 vaccines (2024-2025 formula) to more closely target currently circulating variants to prevent COVID-19 and to provide better ...
Moderna Announces Clinical and Program Updates at 4th …
WEBApr 11, 2023 · Moderna Announces Clinical and Program Updates at 4th Vaccines Day. April 11, 2023. Download. Next-generation, refrigerator-stable COVID-19 vaccine candidate, mRNA-1283, has dosed first participant in its Phase 3 trial. Company expects to file for approval of its investigational RSV vaccine candidate, mRNA-1345, this quarter.
Combined COVID–flu vaccines are coming: Moderna jab clears
WEBJun 28, 2024 · Pharmaceutical laboratories are researching new applications for mRNA vaccine technology — and Moderna is hoping to integrate COVID-19, influenza and respiratory syncytial virus immunization ...
Moderna Says Its Booster Significantly Raises Antibodies …
WEBDec 20, 2021 · A booster shot of the Moderna coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant, the company announced on Monday. The news arrives as Omicron...
Moderna R&D day: $1 billion in cost cuts, 10 product launches
WEBSep 12, 2024 · Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid...
News and Blog Posts - Moderna
WEBRead and download all Moderna-related news related to Moderna's COVID-19 vaccine, boosters, internal updates, and more from the year 2012 through 2022
Moderna says Covid-flu combination vaccine shows positive …
WEBJun 10, 2024 · Vaccine maker Moderna announced positive late-stage trial results for its Covid-flu combination vaccine. There could be a combined Covid-19 and flu shot in our future, although it won’t be ready...
Skip to content